Learn About Updates in Nephrology on Webcast

OSU Wexner Medical Center logo

Learn About Updates in Nephrology on Webcast.  Needless to say, dialysis has come a long, long way in the decades since. But even more important are recent developments in tactics to prevent progression of renal failure in patients with chronic kidney disease, thus avoiding or delaying the need for dialysis. Many of these new preventive concepts have only emerged in the past three or four years. Consequently, most of us did not learn about them during medical school and residency. So today, we’re going to update you in the management of chronic kidney disease. And to do it, we’re pleased to welcome back Dr. Rima Kang, a nephrologist and assistant professor of internal medicine at the Ohio State University.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Describe how to diagnose chronic kidney disease and assess progression.
  • Describe how to manage chronic kidney disease including target blood pressure and renal protective medications.

You’ll also learn about the following:

  • Common nephrotoxins
  • Hemodiafiltration versus hemodialysis
  • Electrolyte management in chronic kidney disease
  • Common reversible causes of worsening renal function
  • Lipid management in chronic kidney disease
  • Bone health and chronic kidney disease

You can find this and many other MedNet21 programs on the OSU – CCME website.

Learn About Latest COVID-19 Vaccine Updates

OSU Wexner Medical Center logo Learn About Latest COVID-19 Vaccine Updates on webcast. Our knowledge of COVID-19 continues to evolve, just as the virus continues to mutate. On April 19, 2023, the CDC and FDA changed their guidance on COVID-19 vaccines. To update us on the latest COVID-19 vaccine data and guidance, WE’ve invited two experts. Emily Vrontos is a Doctor of Pharmacy at the Ohio State University Wexner Medical Center and serves as the Lead specialty practice pharmacist for the Department of Family and Community Medicine. We also have Dr Matthew Washam, an Assistant professor of Pediatrics at Ohio State who practices as a Pediatric Infectious Diseases Specialist at Nationwide Children’s Hospital and is also the Chief of Epidemiology and Infection Prevention there.

What you’ll learn in this webcast

  • Review data supporting COVID-19 vaccination in children and adults
  • Provide an overview of the current CDC recommendations for COVID-19 vaccination in children and adults
  • Discuss frequently encountered questions surrounding COVID-19 vaccination in children and adults

You’ll also learn about the following:

  • Recommendations
  • Future
  • Waning Immunity
  • Vaccine vs Natural Immunity
  • Efficacy
  • Side Effects

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Get An Overview and Updates on Atrial Fibrillation

OSUWexnerbloglogo2014 Get An Overview and Updates on Atrial Fibrillation. To discuss in more depth the most common sustained arrhythmia, Atrial fibrillation, and the updates in management are two of Ohio State University’s cardiology experts. We’re pleased to introduce Assistant Professor of Cardiology Dr. Jim Liu and Assistant Professor of Cardiology Dr. Salvatore Savona. Jim is a noninvasive cardiologist and he will take us through presentation, evaluation, risk factor management and stroke prevention of Afib. And Sal is an Electrophysiologist. His discussion will focus on rate and rhythm control strategies.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Recognize risk factors for atrial fibrillation
  • Understand options for stroke prevention in atrial fibrillation
  • Understand differences in rate and rhythm control strategies for management.
  • Review the role of catheter ablation in the management of atrial fibrillation.

You’ll also learn about the following:

  • Atrial Fibrillation Epidemiology
  • AF Burden
  • Anticoagulation in Women

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn of Updates in the Management of Prediabetes and Type II Diabetes

OSUWexnerbloglogo2014 Learn of Updates in the Management of Prediabetes and and Type II Diabetes. Learn of Updates in the Management of Prediabetes and and Type II Diabetes. The International Diabetes Federation estimates there are 537 million individuals with diabetes worldwide. And that’s not even counting the patients that go undiagnosed. In the US, we estimate that 1/3 of eligible patients are not screened. Even with screening, there’s a gigantic gap in prediabetes diagnosis and treatment. Those in Primary care are really at the forefront of diabetes & prediabetes care. With 11% of the adult population affected by Diabetes, every healthcare worker must become comfortable with the care and treatment of these patients. So today to help Dr. Mao discuss the updates in the prevention and treatment of diabetes, we’ve invited her colleague Jennifer Sabatino who is a Doctor of Pharmacy and practicing Clinical Pharmacist at Ohio State University. They will cover the basics and updates over the past half a decade or so including both non-pharmacologic and pharmacologic treatment options.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Understand the epidemiology and definition of Prediabetes and Type II diabetes (T2DM).
  • Be familiar with the different treatment options for Prediabetes to prevent progression to T2DM.
  • Understand the pharmacologic and non-pharmacologic treatments for T2DM.
  • Recognize the place in therapy of Glucagon-Like Peptide Receptor Agonists (GLP-1 RA) and Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) for T2DM.
  • Explore a new class of medications for diabetes treatment, the Glucose-Dependent Insulinotropic Polypeptide (GIP)/Glucagon-Like Peptide Receptor Agonist (GLP-1 RA).

You’ll also learn about the following:

  • Supplements
  • Prediabetes treatment Outcomes
  • Pregnancy and lactation

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Online Webcast Teaches on Immunization Updates

OSUWexnerbloglogo2014 Online Webcast Teaches on Immunization Updates. Today smallpox has been eradicated in no small part due to Jenner’s efforts. His discovery was only the beginning of vaccination development. Now, there are over 2 dozen vaccine preventable illnesses. Here to update us on the most recent vaccination guidelines as well as the science behind them is Dr Nathan Richards. Nate is an Assistant professor of Internal Medicine at Ohio State University and practices Med-Peds primary care. He has lectured extensively on vaccinations and we’re excited to have him back on the program.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:
Demonstrate a clear understanding of the pediatric and adult vaccination schedule
Apply the 2022 ACIP updates to your clinical practice

You’ll also learn about the following:

  • Safety
  • Co-administration
  • Hepatitis B vaccine
  • Insurance
  • Cancer prevention
  • Boosters

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.